mint Analytics: Real-time data visualization and analysis in clinical trials with imaging endpoints

We talked to PD Dr. Wolfgang G. Kunz, Head of Oncological Imaging and of the Oncological Study Center at the Ludwig Maximilians University Hospital Munich, about his experience with mint Analytics, an extensive add-on of the leading radiological platform mint Lesion™.

Next to the data visualization of multiple trials, PD Dr. Kunz and his team use mint Analytics for quality control of trial site reads and for sharing the current status of trial results with oncological PIs, which provides them with an estimate of what responses can be clinically expected. PD Dr. Kunz also provides an insight into how mint Analytics has the ability to open up new avenues of single and multicentric research projects and how this can benefit other radiologists, oncologists, imaging CROs as well as sponsors.

Related Resources

Related Resources

Real-world data to enhance clinical trial evidence

In randomized controlled trials (RCTs), a vast proportion of patients does not meet the precise inclusion criteria. In oncology, for example,…

Improving interdisciplinary communication when using PI-RADS v2.1

Dr. Robert McFarland shares his experience of using mint Lesion™ at his radiology practice in this brief interview. He talks about the challenges of…

Recording of RSNA 2019 AI theater presentation | Power food for AI

At this year’s RSNA, Mint Medical presented its AI approach to the audience at the AI theater. Tobias Gottmann and Aditya Jayaram highlighted how…